Abstract
Genetic Testing and Molecular Biomarkers Journal is officially retracting the article entitled, “Fibroblast growth factor receptor 4 polymorphisms are associated with coronary artery disease” by Chen et al. 2012;16:952-956; DOI: 10.1089/gmtb.2012.0033. This decision was made as a result of the Journal being contacted by Dr. Carol Reiss, Editor-in-Chief of the journal DNA and Cell Biology, who informed us that a plagiarism report she generated revealed that this article, and two others published by an overlapping group of authors--all at approximately the same time--contain very significant overlaps with titles, abstracts, and introductions that are virtually identical. The other two papers have been identified as: •Ma L, Zhang H, Han C, Tong D, Zhang M, Yao Y, Luo Y, Liu X, entitled, “Fibroblast Growth Factor Receptor 4 Polymorphisms and Susceptibility to Coronary Artery Disease” DNA Cell Biol 31:1064-1069, 2012; DOI: 10.1089/dna.2011.1552. •Zhu Q, Liu T. Fibroblast growth factor receptor 4 polymorphisms and coronary artery disease: a case control study. Mol Bio Report 2012;39:8679-8685; DOI: 10.1007/s11033-012-1723-1728. Genetic Testing and Molecular Biomarkers is committed to upholding the strictest standards of scientific publishing and does not tolerate any impropriety or misconduct.
Get full access to this article
View all access options for this article.